Bridget Keenan, MD, PhD
Dr. Keenan completed her MD and PhD at the Johns Hopkins University School of Medicine, where she focused on using cancer vaccines to overcome immune suppression in the tumor microenvironment in mouse models of pancreatic cancer. She completed her Internal Medicine residency and Hematology/Oncology fellowship at UCSF. During her fellowship, she trained in both gastrointestinal oncology and cancer immunotherapy. She is the Co-Director of the Cancer Immunotherapy Program and Medical Director of the Cancer Immunotherapy Clinic. Her research interests are in studying the mechanisms of response and resistance to immunotherapy, with a focus on gastrointestinal cancers. Clinically, she sees patients with solid tumor malignancies being treated with cutting-edge immunotherapies including cell therapies and T cell engagers.